Tetanus Toxoid Vaccine (e.g., Tdap, Td)
Treatment for Tetanus
Typical Dosage: 0.5 mL intramuscular
Effectiveness
99%
Safety Score
90%
Clinical Trials
1,000
Participants
1M
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
90
DangerousModerateSafe
Treatment Details
Dosage Range
0.5 mL intramuscular
Time to Effect
Weeks to months (after initial series), immediate (booster effect if previously vaccinated)
Treatment Duration
Initial series, then boosters every 10 years or with injury
Evidence Quality
HIGHNumber Needed to Harm (NNH)
1000000(Treat 1000000 patients to see 1 additional serious adverse event)
Confidence Score
99%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$1.5
Monitoring:$600
Side Effect Mgmt:$0.1
Total Annual:$601.6
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$3,000/QALY
QALYs Gained
0.08
Prescription Access Economics
Annual Societal Loss per Patient
$16.5
Cost of prescription-only barriers (visits, time, admin, price premium)
Physician Visit Cost
$20/year
Time Cost
$5/year
Travel + wait time
Insurance Admin Cost
$0.5/year
Prior auth, claims
Rx Price
$1.5/year
Potential OTC Price
$0.5/year
Estimated if OTC available
Early Treatment Benefit
+0.00 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
LOWMissed Diagnosis Risk
LOWTetanus Toxoid Vaccine (e.g., Tdap, Td) Outcomes
for Tetanus
Efficacy Outcomes
Overall Effectiveness
+99%
Response Rate
+99%
Common Side Effects
Local pain/swelling
+30%
Fever
+5%
Headache
+3%
Severe allergic reaction (anaphylaxis)
+0.0001%
Sources:
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov